MP
CXAC.WS

Mangrove Partners’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History

Mangrove Partners’s Portfolio CXAC.WS Stock Details CXAC.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,552
Closed -$105K – 509
2022
Q2 		$105K Buy
+10,552
New +$2.69K 0.01% 500

Other funds holding CXAC.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Mangrove Partners's CXAC.WS Position: Q3 2022 in Review

Mangrove Partners sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q3 2022, closing a stake of 10,552 shares — an estimated $105K sold.

Mangrove Partners first reported a position in CXAC.WS in Q2 2022 and held it in 1 quarter. The position peaked at $105K in Q2 2022. 39 funds tracked by Wall St. Rank hold CXAC.WS as of Q3 2022.

  • Mangrove Partners reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
  • Mangrove Partners sold 10,552 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q3 2022, an estimated $105K.
  • Mangrove Partners first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 1 quarter.
  • Mangrove Partners's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $105K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.